Norgestimate And Ethinyl Estradiol Kit
Product Images NDC 42291-553

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Norgestimate And Ethinyl Estradiol (NDC 42291-553). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avkare, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Blister (553 28 Blister .25 .035)

Norgestimate and Ethinyl Estradiol Tablets USP 0.25 mg/0.035 mg labeling from AvKARE. The label specifies storage at 20° to 25°C (68° to 77°F) and protection from light. It indicates the product is manufactured for AvKARE in Pulaski, TN, and is a product of Spain. The label includes an NDC code 42291-553-28 and a barcode.*

FDA Label Image

Carton (553 84 Carton .25 .035)

Packaging label for Norgestimate and Ethinyl Estradiol Tablets USP 0.25 mg / 0.035 mg in a kit form, labeled by AvKARE. The label includes dosage information, usage directions, and storage instructions. The package contains three units, each with 3 x 28 tablet blister cards.*

FDA Label Image

Blister (Blister Pack)

Norgestimate and Ethinyl Estradiol tablets, USP 0.25 mg / 0.035 mg, depicted in a weekly dosage calendar format. The calendar shows days from Sunday through Saturday over four weeks, with arrows indicating the daily pill sequence. The Week 4 row circles are shaded, suggesting a differentiation in pill type or color for that week. The label is part of a kit by AvKARE.*

FDA Label Image

Chart 1

A vertical chart displaying relative pregnancy rates with various birth control methods. The chart ranks methods from fewer pregnancies per 100 women per year at the top, including implants, injections, intrauterine devices, and sterilization, down to more pregnancies with no birth control, spermicide, withdrawal, and no sex during fertile days listed lower. Birth control pills, skin patch, vaginal ring with hormones, condoms, and diaphragm appear in the middle range.*

FDA Label Image

Ethinyl (Ethinyl Estradiol)

Chemical structure of Ethinyl Estradiol shown as a molecular diagram, highlighting the arrangement of carbon, hydrogen, and oxygen atoms in the active ingredient. The structure includes characteristic rings and functional groups relevant to ethinyl estradiol.*

FDA Label Image

Figure 2

A forest plot chart titled 'Risk of Breast Cancer with Combined Oral Contraceptive Use' showing effect estimates (Odds Ratio or Relative Risk) from various studies comparing breast cancer risk in females with current or past use of combined oral contraceptives (COC) versus never use. The chart includes study names and years, with horizontal lines and markers representing risk estimates and confidence intervals across a range from below 0 to above 1.5 on the x-axis.*

FDA Label Image

Norgestimate (Norgestimate)

Chemical structure diagram of Norgestimate, showing its molecular configuration with labeled atoms and bonds. The structure highlights key groups including hydroxyl and ester functionalities.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.